What's Behind Guardant Health's Disappointing Q4 Results
Guardant Health (NASDAQ: GH) started 2021 with a bang. The stock soared 39% year to date at one point earlier this month. It has since given up more than half of that gain, though, and its shares are likely to fall even more.
The liquid biopsy pioneer announced its fourth-quarter results after the market closed on Wednesday. The healthcare stock slid nearly 7% in after-hours trading. Here are the highlights from Guardant Health's Q4 update.
Image source: Getty Images.
Source Fool.com
